Position in BLLN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$121,218,432
+$62,998,762 QoQ
Shares Held
1,010,322
+37.0% QoQ
Ownership
2.14%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#2
of 156 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BLLN Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $14,000,860,485 across 31 Diagnostics & Research names. BLLN ranks #15 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
5,116,336 | $2,565,126,216 | |
| 2 | NTRA |
Natera, Inc.
|
9,021,895 | $2,448,993,397 | |
| 3 | DHR |
Danaher Corp /De/
|
11,450,715 | $2,181,132,192 | |
| 4 | DGX |
Quest Diagnostics Inc
|
5,444,986 | $1,154,064,781 | |
| 5 | MEDP |
Medpace Holdings, Inc.
|
2,069,677 | $1,096,080,242 | |
| 6 | GH |
Guardant Health, Inc.
|
6,514,952 | $977,438,248 | |
| 7 | WAT |
Waters Corp /De/
|
2,177,958 | $816,821,367 | |
| 8 | RVTY |
Revvity, Inc.
|
5,530,850 | $615,362,370 |
All Filings in BLLN
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $121,218,432 | 1,010,322 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $58,219,670 | 737,518 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $39,715,560 | 485,283 | Shares | Sole | 2026-02-17 | |
| No filing history on record for this holder in this stock. | ||||||